![Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology - ScienceDirect Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S093964112100151X-ga1.jpg)
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology - ScienceDirect
![Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199319308331-gr1.jpg)
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis - ScienceDirect
![Mean amikacin serum concentrations during the 24 h period following the... | Download Scientific Diagram Mean amikacin serum concentrations during the 24 h period following the... | Download Scientific Diagram](https://www.researchgate.net/profile/Stephan-Ehrmann/publication/5800487/figure/fig3/AS:277672988037127@1443213807773/Mean-amikacin-serum-concentrations-during-the-24-h-period-following-the-beginning-of_Q320.jpg)
Mean amikacin serum concentrations during the 24 h period following the... | Download Scientific Diagram
![These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE® (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S. These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE® (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=arikayce-27.jpg&id=733393)
These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE® (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S.
![Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00134-007-0935-1/MediaObjects/134_2007_935_Fig1_HTML.gif)
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
![Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-86342-8/MediaObjects/41598_2021_86342_Fig1_HTML.png)
Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports
![PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)](https://mma.prnewswire.com/media/753414/Lamira_Nebulizer_System.jpg?w=200)
PARI Pharma's eFlow® Technology device, LAMIRA™, approved as the only nebulizer system to deliver Insmed's ARIKAYCE® (amikacin liposome inhalation suspension)
![Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine](https://medicineinnovates.com/wp-content/uploads/2022/03/external-figure.jpg)
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the PARI eFlow® Technology - Medicine
![Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections - ScienceDirect Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S037851732300159X-ga1.jpg)